Healios K.K. (OTCMKTS:HLOSF – Get Free Report)’s share price was up 42.5% during trading on Monday . The company traded as high as $2.75 and last traded at $2.75. Approximately 400 shares traded hands during trading, a decline of 77% from the average daily volume of 1,714 shares. The stock had previously closed at $1.93.
Healios K.K. Price Performance
The stock has a 50 day moving average price of $2.07 and a 200-day moving average price of $2.97.
About Healios K.K.
Healios K.K. is a Tokyo–based biotechnology company focused on the development and commercialization of regenerative medicine products and services. The company’s core expertise lies in induced pluripotent stem cell (iPSC)–derived therapies, with a pipeline that includes retinal pigment epithelium (RPE) cells for age‐related macular degeneration and neural cell products targeting neurological disorders. Healios operates a specialized cell processing center in Chuo‐ku, Tokyo, adhering to stringent quality standards for clinical‐grade cell manufacturing.
Beyond its proprietary programs, Healios provides contract development and manufacturing services (CDMO) to pharmaceutical and research institutions.
Further Reading
- Five stocks we like better than Healios K.K.
- Buy this Gold Stock Before May 15th, 2026
- America’s 1776 happening again
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
- My Epstein Story
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
